| 9 | Interventional treatment options for management of delayed arterial hemorrhage after major hepato-pancreatic-biliary surgery显示文摘Hilar cholangiocarcinoma is a biliary malignancy arising from the perihilar biliary tree,which is associated with poor oncological outcomes due to its aggressive biology,chemo-resistance and insidious onset[1].As stated by Di Martino et al.,the standard of care is radical resection,and during the last decades,there have been great efforts to improve survival of potentially resectable hilar cholangiocarcinoma,with surgery being the treatment associated with longer survival[2].However,radical resection still represents a challenging operation with high risk of intraoperative and postoperative complications. | Benedetto Ielpo Salvatore Alborino Emmanuel Melloul Fabio Salvatori Quirino Lai Massimo Rossi Nicolas Demartines Salomone Di Saverio | 2023 | Hepatobiliary & Pancreatic Diseases International2023，22，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员